Receipt of a decision to grant a patent from the European Patent Office for a strategic patent application related to Op2Lysis O2L-001 program for hemorrhagic stroke patients.
See the press release below
————————- Our team ————————-
“Our ambition is to become a leader in research and development for stroke.”
117, avenue Victor Hugo, 92100 Boulogne-Billancourt